Powering innovative medical research through the 3D Assay Platform
About ReaGene
We’re an innovative healthcare company established in 2016 with offices and labs in Hyderabad and Bangalore. We have been making great strides in developing tools and platforms that can significantly improve the translatability of preclinical R&D, while creating cost-effective alternatives to animal testing.
Our Mission
To Establish A Translational Assay Platform That Can
Innovate
Significantly increase the translatability of pre-clinical research into human outcomes
Improve
Eliminate hurdles and enhance cost-efficiency & quality across the R&D value chain
Change
Bring genuine alternatives to animal use in biological research in India
Serve
Serve multiple industries involved in research to bring about positive change
ReaGene Biosciences announces filing of PCT for its proprietary 3D printing platform for Drug Discovery and Development..
Our Partners
ProdigY Biotech
Kyntox
Tech Mahindra
Issar Pharma
Trana Labs
Indras
Recognition
Economic Times Entrepreneurial Award, 2019
AEGIS GRAHAM BELL AWARD
We are proud to announce that Reagene Biosciences, Tech Mahindra and Indras joint collaboration on combining Artificial Intelligence & 3D Human Vascular Lung platform for drug repurposing using covid-19 as a model disease - was considered as Finalist for Aegis Graham Bell Award, for the year 2022, from the Government of India.
This is an example where we prove that Strategic multi disciplinary collaborations and team work can help reach several milestones . Congratulations to all the team players especially Dr. Uday Saxena @reagene biosciences. Ratnakar Palakodeti@ tech mahindra, Sreedhara Voleti @ Indras for an excellent and successful joint collaboration.
3D robotic CAD inkjet bio-printing of human vascular lung model
Bengaluru
Ara Viji Trade Square, #21, Chandra Layout,
Jnana Bharathi Main Road, Nagarbhavi Circle,
Bengaluru 560072